{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T23:28:59Z","timestamp":1786318139425,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,9]]},"DOI":"10.7759\/cureus.114227","type":"journal-article","created":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T22:53:07Z","timestamp":1786315987000},"source":"Crossref","is-referenced-by-count":0,"title":["Early-Onset Euglycemic Diabetic Ketoacidosis Following Empagliflozin Initiation Triggered by Acute Influenza and a Ketogenic Diet"],"prefix":"10.7759","author":[{"given":"Madison S","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmithaa","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Rammouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshanah","family":"Lasry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Sawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16162965","article-title":"SGLT2 inhibitors: a review of their antidiabetic and cardioprotective effects","volume":"16","author":"Tentolouris A","year":"2019","unstructured":"Tentolouris A, Vlachakis P, Tzeravini E, Eleftheriadou I, Tentolouris N. SGLT2 inhibitors: a review of their antidiabetic and cardioprotective effects. Int J Environ Res Public Health. 2019, 16:2965. 10.3390\/ijerph16162965","journal-title":"Int J Environ Res Public Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2023-003666","article-title":"Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors","volume":"11","author":"Chow E","year":"2023","unstructured":"Chow E, Clement S, Garg R. Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors. BMJ Open Diabetes Res Care. 2023, 11:e003666. 10.1136\/bmjdrc-2023-003666","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i5.514","article-title":"Euglycemic diabetic ketoacidosis: a missed diagnosis","volume":"12","author":"Nasa P","year":"2021","unstructured":"Nasa P, Chaudhary S, Shrivastava PK, Singh A. Euglycemic diabetic ketoacidosis: a missed diagnosis. World J Diabetes. 2021, 12:514-23. 10.4239\/wjd.v12.i5.514","journal-title":"World J Diabetes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2020_533","article-title":"Latent autoimmune diabetes in adults: a review of clinically relevant issues","author":"Hern\u00e1ndez M","year":"2020","unstructured":"Hern\u00e1ndez M, Mauricio D. Latent autoimmune diabetes in adults: a review of clinically relevant issues. Diabetes: From Research to Clinical Practice. Advances in Experimental Medicine and Biology. Islam MS (ed): Springer, Cham; 2020. 1307:29-41. 10.1007\/5584_2020_533"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2019.12.006","article-title":"Beware ketoacidosis with SGLT2 inhibitors in latent autoimmune diabetes of the adult","volume":"133","author":"Nolan BJ","year":"2020","unstructured":"Nolan BJ, Varadarajan S, Fourlanos S, Neoh SL. Beware ketoacidosis with SGLT2 inhibitors in latent autoimmune diabetes of the adult. Am J Med. 2020, 133:e422-4. 10.1016\/j.amjmed.2019.12.006","journal-title":"Am J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.959011","article-title":"Latent autoimmune diabetes in adults: a focus on \u03b2-cell protection and therapy","volume":"13","author":"Yin W","year":"2022","unstructured":"Yin W, Luo S, Xiao Z, Zhang Z, Liu B, Zhou Z. Latent autoimmune diabetes in adults: a focus on \u03b2-cell protection and therapy. Front Endocrinol (Lausanne). 2022, 13:959011. 10.3389\/fendo.2022.959011","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2834","article-title":"Latent autoimmune diabetes of adults (LADA) is likely to represent a mixed population of autoimmune (Type 1) and nonautoimmune (Type 2) diabetes","volume":"44","author":"Jones AG","year":"2021","unstructured":"Jones AG, McDonald TJ, Shields BM, Hagopian W, Hattersley AT. Latent autoimmune diabetes of adults (LADA) is likely to represent a mixed population of autoimmune (Type 1) and nonautoimmune (Type 2) diabetes. Diabetes Care. 2021, 44:1243-51. 10.2337\/dc20-2834","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e3182376cc4","article-title":"H1N1 influenza: the trigger of diabetic ketoacidosis in a young woman with ketosis-prone diabetes","volume":"343","author":"Tan H","year":"2012","unstructured":"Tan H, Wang C, Yu Y. H1N1 influenza: the trigger of diabetic ketoacidosis in a young woman with ketosis-prone diabetes. Am J Med Sci. 2012, 343:180-3. 10.1097\/MAJ.0b013e3182376cc4","journal-title":"Am J Med Sci"},{"key":"ref9","article-title":"Hyperglycemic crises","author":"Dhatariya K","year":"2000","unstructured":"Dhatariya K, Mustafa O, Stathi D. Hyperglycemic crises. Endotext [Internet]. Feingold KR, Adler RA, Ahmed SF, et al. (ed): MDText.com, Inc., South Dartmouth (MA); 2000."},{"key":"ref10","article-title":"Adult diabetic ketoacidosis","author":"Lizzo JM","year":"2025","unstructured":"Lizzo JM, Goyal A, Kaur J. Adult diabetic ketoacidosis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.96393","article-title":"Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter 2 (SGLT2) inhibitors: a case series and clinical reflections","volume":"17","author":"Sultan A","year":"2025","unstructured":"Sultan A, Naeem MN, Javed N, Rehman M, Danial A. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter 2 (SGLT2) inhibitors: a case series and clinical reflections. Cureus. 2025, 17:e96393. 10.7759\/cureus.96393","journal-title":"Cureus"},{"key":"ref12","article-title":"Sodium-glucose transport 2 (SGLT2) inhibitors","author":"Padda IS","year":"2025","unstructured":"Padda IS, Mahtani AU, Parmar M. Sodium-glucose transport 2 (SGLT2) inhibitors. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174145","article-title":"SGLT2i increased the plasma fasting glucagon level in patients with diabetes: a meta-analysis","volume":"903","author":"Zhu X","year":"2021","unstructured":"Zhu X, Lin C, Li L, Hu S, Cai X, Ji L. SGLT2i increased the plasma fasting glucagon level in patients with diabetes: a meta-analysis. Eur J Pharmacol. 2021, 903:174145. 10.1016\/j.ejphar.2021.174145","journal-title":"Eur J Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-020-02607-2","article-title":"Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type\u00a02 diabetes mellitus: a case report","volume":"15","author":"Vadasz B","year":"2021","unstructured":"Vadasz B, Arazi M, Shukha Y, Koren O, Taher R. Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type\u00a02 diabetes mellitus: a case report. J Med Case Rep. 2021, 15:62. 10.1186\/s13256-020-02607-2","journal-title":"J Med Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1365","article-title":"Clinical applications of diabetes antibody testing","volume":"95","author":"Bingley PJ","year":"2010","unstructured":"Bingley PJ. Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab. 2010, 95:25-33. 10.1210\/jc.2009-1365","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/nu15143120","article-title":"The effects of ketogenic diet on insulin sensitivity and weight loss, which came first: the chicken or the egg?","volume":"15","author":"Paoli A","year":"2023","unstructured":"Paoli A, Bianco A, Moro T, Mota JF, Coelho-Ravagnani CF. The effects of ketogenic diet on insulin sensitivity and weight loss, which came first: the chicken or the egg?. Nutrients. 2023, 15:3120. 10.3390\/nu15143120","journal-title":"Nutrients"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12159","article-title":"The clinical utility of C-peptide measurement in the care of patients with diabetes","volume":"30","author":"Jones AG","year":"2013","unstructured":"Jones AG, Hattersley AT. The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med. 2013, 30:803-17. 10.1111\/dme.12159","journal-title":"Diabet Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/515003-early-onset-euglycemic-diabetic-ketoacidosis-following-empagliflozin-initiation-triggered-by-acute-influenza-and-a-ketogenic-diet","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T22:53:08Z","timestamp":1786315988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/515003-early-onset-euglycemic-diabetic-ketoacidosis-following-empagliflozin-initiation-triggered-by-acute-influenza-and-a-ketogenic-diet"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,9]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.114227","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,9]]}}}